**7. References**

Ashida Y. and Denda M. (2001) Histamine H1 and H2 receptor antagonists accelerate skin barrier repair and prevent epidermal hyperplasia induced by barrier disruption in a dry environment. J Invest Dermatol 11 ,261-265, 2001

Fig. 5. Schematic illustration of the effect of mental stress on the endocrine system and on

Epidermal barrier dysfunction is observed in a variety of skin diseases, such as atopic dermatitis, psoriasis, and contact dermatitis, and barrier disruption induces an inflammatory response that might aggravate dermatitis (Grice 1980). On the other hand, acceleration of barrier recovery was shown to improve epidermal hyperplasia (Denda 1997)(Fuziwara 2004). Since a wide range of physical or chemical factors, as described here, influence barrier homeostasis, control or modulation of these factors is expected to open up new possibilities for the treatment of human skin diseases involving barrier abnormality.

Ashida Y. and Denda M. (2001) Histamine H1 and H2 receptor antagonists accelerate skin

a dry environment. J Invest Dermatol 11 ,261-265, 2001

barrier repair and prevent epidermal hyperplasia induced by barrier disruption in

skin barrier function.

**6. Conclusion** 

**7. References** 


Physical and Chemical Factors that Improve Epidermal Permeability Barrier Homeostasis 211

Fuziwara S., Suzuki A., Inoue K., Denda M., (2005) Dopamine D2-like receptor agonists

Garg, A., Chren, M.M., Sands, L.P., Matsui, M.S., Marenus, K.D., Feingold, K.R., Elias, P.M.

Ghadially R, Brown BE., Sequeira-Martin SM., Feingold KR, Elias PM, (1995) The aged

Ghadially R, Brown BE, Hanley K, Reed JT, Feingold KR, Elias PM, (1996) Decreased

Gick B, Derrick D. (2009) Aero-tactile integration in speech perception. Nature. 462: 502-4. Goto M, Ikeyama K, Tsutsumi M, Denda S, Denda M. (2011) Phosphodiesterase inhibitors

Grice KA. (1980) Transepidermal water loss in pathologic skin. In: Jarrett A (ed) The

Hachem JP, Houben E, Crumrine D, Man MQ, Schurer N, Roelandt T, Choi EH, Uchida Y,

Hanley K.M. Rassner U., Jiang Y., Vansomphone D., Crumurine D., Komuves L., Elias P.M.,

Hanley K, Kömüves LG, Ng DC, Schoonjans K, He SS, Lau P, Bikle DD, Williams ML, Elias

Haratake A, Ikenaga K, Katoh N, Uchiwa H, Hirano S, Yasuho H, (2000) Topical mevalonic

Heffner RS. (2004) Primate hearing from a mammalian perspective. Anat Rec A Discov Mol

Ikeyama, K., Fuziwara, S., Denda, M. (2007) Topical application of neuronal nitric oxide

permeability barrier homeostasis. J Invest Dermatol.126:2074-86.

keratinocytes via PPARalpha. J Biol Chem. 275:11484-91

homeostasis in aged mice. J Invest Dermatol 114:247-252

disruption. J invest Dermatol 125: 783-789

Dermatol. 137, 53-59

20:568-57

Invest Dermatol 106: 1064-1069

testosterone. J Clin Invest 97:2576-2584

Cell Evol Biol 281:1111-1122.

epidermis. J. Clin. Invest. 89, 530-538

vs physiologic lipids. Arch Dermatol 131:809-816

accelerate barrier repair and inhibit the epidermal hyperplasia induced by barrier

(2001) Psychological stress perturbs epidermal permeability barrier homeostasis: implications for the pathogenesis of stress-associated skin disorders. Arch

epidermal permeability barrier. Structural, functional, and lipid biochemical abnormalities in humans and asenescent murine model. J Clin Invest 95: 2281-2290

epidermal lipid synthesis accounts for altered barrier function in aged mice. J

block the acceleration of skin permeability barrier repair by red light. Exp Dermatol

Physiology and Pathophysiology of the Skin. Academic Press, London, UK; 2147-55

Brown BE, Feingold KR, Elias PM. (2006) Serine protease signaling of epidermal

Feingold K.R., Williams M.L. (1996) Hormonal basis for the gender difference in epidermal barrier formation in the fetal rat. Acceleration by estrogen and delay by

PM, Auwerx J, Feingold KR. (2000) Farnesol stimulates differentiation in epidermal

acid stimulates de novo cholesterol synthesis and epidermal permeability barrier

synthase inhibitor accelerates cutaneous barrier recovery and prevents epidermal hyperplasia induced by barrier disruption. J Invest Dermatol 127, 1713-1719, 2007 Inoue K, Koizumi S, Fuziwara S, et al. (2002) Functional vanilloid receptors in cultured normal human keratinocytes. Biochem Biophys Res Commun 291:124-129 Kawai N, Honda M, Nakamura S, et al. (2001) Catecholamines and opioid peptides increase in plasma in humans during possession trances. Neuroreport 12:3419-23. Lee, S.H., Elias, P.M., Proksch, E., Menon, G.K., Man, M.Q., Feingold, K.R., (1992) Calcium

and potassium are important regulators of barrier homeostasis in murine

Man MQ, Brown BE, Wu-Pong S, Feingold KR, Elias PM. (1995) Exogenous nonphysiologic


Denda, M., Katagiri, C., Maruyama, N. (1999) Some magnesium salts and a mixture of

Denda, M., Kitamura, K., Elias, P.M., Feingold, K.R., (1997) Trans-4-(aminomethyl)

Denda M., Nakanishi K., Kumazawa N. (2005) Topical application of ionic polymers affects

Denda, M., Sokabe, T., Tominaga, T., Tominaga, M. (2007) Effects of skin surface

Denda, M., Tshuchiya, T., Hosoi, J., (1998) Immobilization-induced and crowded

Denda, M., Tsuchiya, T., Elias, P.M., Feingold, K.R., (2000) Stress alters cutaneous permeability barrier homeostasis. Am J Physiol 278, R367-R372 (2000) Denda, M. and Tsuchiya, T., (2001) Barrier recovery rate varies time-dependently in human

Denda, M., Tsuchiya, T., Shoji, K., Tanida, M. (2000) Odorant inhalation affects skin barrier

Denda, M., Tanida, M., Shoji, K., Tsuchiya, T. (2000) Inhalation of a sedative odorant

Denda S., Kumamoto S., Takei K., Tsutsimi M., Aoki H., Denda M., Ryanodine receptors are

Feingold KR. (1999) Role of nuclear hormone receptors in regulating epidermal

Feingold KR, (2000) Farnesol stimulates differentiation in epidermal keratinocytes via

Feingold, K.R., Elias, P.M. (2000) The environmental interface: regulation of permeability

Friel DD. TRP: its role in phototransduction and store-operated Ca2+ entry. Cell.1996; 85:617-9. Fuziwara, S., Inoue, K., Denda, M. (2003) NMDA-type glutamate receptor is associated with cutaneous barrier homeostasis. J Invest Dermatol 120, 1023-1029, 2003 Fuziwara S., Ogawa K., Aso D., Yoshizawa D., Takata S., Denda M. (2004) Barium sulfate

and Maibach HI ed) pp45-58 CRC Press, Boca Raton, USA (2000)

prevents the delay of cutaneous barrier repair induced by psychological stress. The

expressed in epidermal Keratinocytes and assosiated with Keratinocyte differentiation and epidermal permeability barrier homeostasis. J. Invest Dermatol

diffrentiation. Program and Preprints of Annual Scientific Seminar, Society of

barrier homeostasis. In *Dry Skin and Moisturizers. Chemistry and Function*. (Loden M

with a negative z potential accelerates skin permeable barrier recovery and prevents epidermal hyperplasia indueced by barrier disruption. Br J Dermarol

homeostasis in mice and humans. Br J Dermatology 142, 1007-1010

injury in hairless mice and humans. J. Invest Dermatol 109, 84-90

291, 560-563, 1999

41,2005

654-659.

138, 780-785

2011 in press.

151:557-564

skin. Br. J. Dermatol 142, 881-884

Cosmetic Chemists.(1999) 30-31

PPARalpha. J Biol Chem. 275: 11484-91.

Autonomic Nervous System 37, 419-424,2000

magnesium and calcium salts accelerate skin barrier recovery. Arch Dermatol Res

cyclohexane carboxylic acid (t-AMCHA), an anti-fibrinolytic agent, accelerates barrier recovery and prevents the epidermal hyperplasia induced by epidermal

skin permeability barrier homeostasis. Skin Pharmacology and Physiology 18:36-

temperature on epidermal permeability barrier homeostasis. J Invest Dermatol 127,

environment-induced stress delay barrier recovery in murine skin. Br. J. Dermatol.


**13** 

Evmorfia Ladoyanni

*United Kingdom*

**Trigger Factors, Allergens and** 

*Vicarage Road, Stourbridge, West Midlands* 

**Allergy Testing in Atopic Dermatitis** 

*Department of Dermatology, Dudley Group Hospitals, Corbett Hospital* 

Atopic dermatitis (AD) is a chronic inflammatory skin disorder affecting between 10-20% of children and 1-3% of adults in the general population. It is associated with high morbidity and has major public health implications. AD is associated with hyper-reactivity of the skin to environmental trigger factors that are harmless in normal individuals. Major contributors to this hyperactivity are the many immune and inflammatory changes taking place in the skin and peripheral blood in AD individuals. AD can be classified into several subgroups, each with different immune and pathological features, suggesting a multifactorial disease and heterogeneity. Historically two types of AD have been identified. They include the "extrinsic or allergic" type of AD, which is characterized by Immunoglobulin E (IgE) mediated sensitization (immediate, type I hypersensitivity) and occurs in 70-80% of individuals. The "non-allergic or intrinsic" type of AD affects 20-30% of individuals and is defined by a more T-cell driven feature (delayed, type IV hypersensitivity), with low IgE levels and absent IgE sensitization. More recently a transition from the intrinsic to the extrinsic type has been reported in young children, and AD individuals can show a combination of above mentioned phenotypes or complete absence of the known features. The clinical diagnosis of AD does not cause major difficulties as there are fairly well defined criteria. Identifying the underlying pathophysiology for the affected individual can be more of a challenge, as there is no gold standard test available for AD and the AD individual might move from one pathophysiological "type" of AD to another. Clinically AD is divided into acute, subacute and chronic forms with correlated histopathological changes. The transition from one clinical form to another is fluent and can be very rapid. AD individuals frequently give a personal and or a family history of asthma and allergic rhinitis, the so called atopic triad. Exacerbation of one of the disorders in this triad can cause concomitant exacerbation of the other two suggesting some underlying common pathways and

Predisposing factors for AD are multifactorial and involve genetic susceptibility, defects in skin barrier function, immune dysregulation, western life style and exposure to environmental trigger factors. The development of disease is an interplay of gene-gene and gene-environment interactions. The early age of onset and familial predisposition as well as the high concordance rate of AD in monozygotic (77%) and dizygotic (15%) twins suggest a

**1. Introduction** 

interdependence (Reitamo et al., 2008).

